| # | Drug | Count |
|---|---|---|
| 0 | CABOZANTINIB | 13 |
| 1 | EMPAGLIFLOZIN | 4 |
| 2 | NIVOLUMAB | 4 |
| 3 | PREDNISONE | 4 |
| 4 | AXITINIB | 3 |
| 5 | DAPAGLIFLOZIN | 3 |
| 6 | DUPILUMAB | 3 |
| 7 | ACETAMINOPHEN | 2 |
| 8 | ACETAMINOPHEN 500MG | 2 |
| 9 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXTRAN, HYPROMELLOSE | 1 | 0.0043 |
| 1 | ERYTHROMYCIN ETHYLSUCCINATE | 1 | 0.0016 |
| 2 | ERDAFITINIB | 2 | 0.0016 |
| 3 | MINERAL OIL | 1 | 0.0007 |
| 4 | CABOZANTINIB | 13 | 0.0003 |
| 5 | FLUOCINOLONE ACETONIDE | 1 | 0.0003 |
| 6 | ENFORTUMAB VEDOTIN | 2 | 0.0003 |
| 7 | HYDROCORTISONE SODIUM SUCCINATE | 1 | 0.0003 |
| 8 | ENTECAVIR | 2 | 0.0002 |
| 9 | AXITINIB | 3 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 1 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 2 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 5 | 0.0000 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 4 | 0.0000 |
| 5 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Anti-IgE [EPC] | 2 | 0.0000 |
| 7 | Purine Antimetabolite [EPC] | 2 | 0.0000 |
| 8 | Aminosalicylate [EPC] | 2 | 0.0000 |
| 9 | Macrolide Antimicrobial [EPC] | 1 | 0.0000 |